Login / Signup

Toxic Advanced Glycation End-Products-Dependent Alzheimer's Disease- Like Alternation in the Microtubule System.

Hayahide OoiYoshiki Koriyama
Published in: Current Alzheimer research (2024)
Type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's Disease (AD). However, the detailed mechanism underlying T2DM-related AD remains unknown. In DM, many types of advanced glycation end-products (AGEs) are formed and accumulated. In our previous study, we demonstrated that Glyceraldehyde (GA)-derived Toxic Advanced Glycation End-products (Toxic AGEs, TAGE) strongly showed cytotoxicity against neurons and induced similar alterations to those observed in AD. Further, GA induced dysfunctional neurite outgrowth via TAGE-β-- tubulin aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau phosphorylation. Herein, we provide a perspective on the possibility that T2DM increases the probability of AD onset and accelerates its progression.
Keyphrases
  • glycemic control
  • pet ct
  • high glucose
  • diabetic rats
  • cognitive decline
  • drug induced
  • type diabetes
  • spinal cord
  • endothelial cells
  • oxidative stress
  • cardiovascular disease
  • metabolic syndrome
  • protein kinase